Artisan Plastic Surgery and Artisan Beauté have been acquired by Olympus Cosmetic Group
Olympus Cosmetic Group, a platform providing comprehensive cosmetic surgery, dermatological treatments and non-surgical cosmetic procedures, has completed the acquisition of Artisan Plastic Surgery, LLC and Artisan Beauté, LLC (collectively Artisan), a female-founded and managed cosmetic surgery and medspa enterprise.
Artisan is a premier US cosmetic and reconstructive plastic surgery practice and luxury medspa business serving patients in the metro Atlanta region and beyond since 2000. Headquartered in Atlanta, Artisan operates four locations that provide leading-edge treatments to patients. Supported by a talented team of female surgeons, its highly complementary Artisan Beauté medspa locations provide patients with access to Artisan’s comprehensive and skillfully performed non-surgical aesthetic procedures.
Olympus is a provider of comprehensive cosmetic surgery, dermatological treatments and non-surgical cosmetic procedures located in Southeast USA. It is a portfolio company of VSS Capital Partners, which was founded in 1987 and is headquartered in New York. VSS is a private investment firm that invests in lower middle-market healthcare, business services and education companies.
Oaklins TM Capital in the USA served as the exclusive financial advisor to Artisan Plastic Surgery and Artisan Beauté in its sale to Olympus Cosmetic Group.
Dr. Diane Alexander
Founder, Artisan Plastic Surgery
Talk to the deal team
James S. Grien
Oaklins TM Capital
Michael S. Goldman
Oaklins TM Capital
Related deals
MEDIK Hospital Design Group has been acquired by STERIS
The private shareholders of MEDIK Hospital Design Group have sold their shares to STERIS plc. Together, MEDIK and STERIS will expand their offerings for hospitals and ambulatory surgery centers worldwide. MEDIK’s solutions ideally complement STERIS’ existing portfolio, enabling the combined group to strengthen its position as a leading provider of turnkey room solutions in surgical and IPT environments. The MEDIK management team will actively support the next phase of growth.
Learn morebioXXmed AG has sold Rancoderm GmbH to Rose Investment- und Beteiligungs AG
Rancoderm GmbH has been acquired by Rose Investment- und Beteiligungs AG to secure the funding required for the final development and market approval of its medical device DermaPro. The acquisition will enable Rancoderm to bring DermaPro to market readiness and launch it as a certified medical product for broad distribution.
Learn moreSLT has been acquired by Indutrade
SLT S.r.l. has been acquired by Indutrade AB and will be integrated into the group’s life science business area. The transaction is Indutrade’s fifth acquisition in 2025 and is expected to have a marginally positive impact on the group’s earnings per share.
Learn more